🇺🇸 FDA
Patent

US 10772865

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

granted A61KA61K31/355A61K31/4709

Quick answer

US patent 10772865 (Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy) held by Coherus BioSciences, Inc. expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/355, A61K31/4709, A61P, A61P1/16